Balance Sheet
Cash Flow Statement
AmortizationAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Legend Biotech (LEGN) Cash from Investing Activities (2019 - 2025)

Historic Cash from Investing Activities for Legend Biotech (LEGN) over the last 7 years, with Q3 2025 value amounting to -$20.0 million.

  • Legend Biotech's Cash from Investing Activities fell 10607.79% to -$20.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$16.7 million, marking a year-over-year increase of 9529.04%. This contributed to the annual value of -$850.5 million for FY2024, which is 101667.28% down from last year.
  • According to the latest figures from Q3 2025, Legend Biotech's Cash from Investing Activities is -$20.0 million, which was down 10607.79% from -$165.5 million recorded in Q2 2025.
  • In the past 5 years, Legend Biotech's Cash from Investing Activities registered a high of $407.5 million during Q4 2023, and its lowest value of -$695.6 million during Q2 2024.
  • Over the past 5 years, Legend Biotech's median Cash from Investing Activities value was -$87.8 million (recorded in 2024), while the average stood at -$65.8 million.
  • Within the past 5 years, the most significant YoY rise in Legend Biotech's Cash from Investing Activities was 153448.18% (2023), while the steepest drop was 480727.27% (2023).
  • Quarter analysis of 5 years shows Legend Biotech's Cash from Investing Activities stood at -$195.0 million in 2021, then skyrocketed by 112.79% to $24.9 million in 2022, then skyrocketed by 1534.48% to $407.5 million in 2023, then plummeted by 121.56% to -$87.8 million in 2024, then surged by 77.23% to -$20.0 million in 2025.
  • Its Cash from Investing Activities was -$20.0 million in Q3 2025, compared to -$165.5 million in Q2 2025 and $256.6 million in Q1 2025.